STRS Ohio’s Olema Pharmaceuticals OLMA Stock Holding History

STRS Ohio’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Buy	12,800 +2,300	+22%	+$30.8K	﹤0.01%	1697
2026 Q1	$157K	Hold	10,500	–	–	﹤0.01%	1592
2025 Q4	$263K	Buy	+10,500	New	+$187K	﹤0.01%	1397
2022 Q2	–	Sell	-4,000	Closed	-$17K	–	2213
2022 Q1	$17K	Hold	4,000	–	–	﹤0.01%	2060
2021 Q4	$37K	Buy	4,000 +1,900	+90%	+$39.4K	﹤0.01%	2045
2021 Q3	$57K	Hold	2,100	–	–	﹤0.01%	2052
2021 Q2	$58K	Sell	2,100 -800	-28%	-$22.8K	﹤0.01%	2086
2021 Q1	$96K	Buy	+2,900	New	+$124K	﹤0.01%	1952

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

STRS Ohio's OLMA Position: Q2 2026 in Review

STRS Ohio increased its Olema Pharmaceuticals (OLMA) stake by 22% in Q2 2026, buying an estimated $30.8K and bringing the position to 12,800 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

STRS Ohio first reported a position in OLMA in Q1 2021 and has held it in 8 quarters since. The position peaked at $263K in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

STRS Ohio held 12,800 shares of Olema Pharmaceuticals worth $160K as of Q2 2026.
STRS Ohio bought 2,300 Olema Pharmaceuticals shares in Q2 2026, an estimated $30.8K.
Olema Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1697 holding.
STRS Ohio first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
STRS Ohio's Olema Pharmaceuticals position peaked at $263K in Q4 2025.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.